Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05153278 · ClinicalTrials.gov registry record
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
A clinical trial, sponsored by Texas Tech University Health Sciences Center, El Paso.
- Completed
- Registry status
- 130
- Enrollment target
NCT05153278 is a clinical trial that has completed, run by Texas Tech University Health Sciences Center, El Paso. The registered enrollment target is 130 participants.
The verdict
NCT05153278 has completed, sponsored by Texas Tech University Health Sciences Center, El Paso.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The investigators will retrospectively collect data of patients infused at UMC's emergency department (ED) with long acting irons (ferric carboxymaltose, iron dextran, iron sucrose, etc.), in addition, patients infused with blood products, with intent to treat iron deficiency anemia (IDA). Patient records reviewed will be from patients who were infused at UMC ED from January 2013 to June 2018. Primary aim of analysis will be to investigate superiority between interventions implemented for treating IDA. In addition, the investigators will utilize data to characterize patients who used ED services as an avenue to receive treatment for IDA. Further, the investigators will conduct cost analysis between different IDA directed treatments administered in the ED at UMC.
Interventions
- DRUG Intravenous drug
- BIOLOGICAL Packed red blood cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2018-10-26 |
| Est. Completion | 2020-08-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05153278
The ClinicalTrials.gov registry entry for NCT05153278 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, El Paso, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intravenous drug is the first listed.
NCT05153278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05153278 about?
NCT05153278 is a clinical study titled "IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department". The investigators will retrospectively collect data of patients infused at UMC's emergency department (ED) with long acting irons (ferric carboxymaltose, iron dextran, iron sucrose, etc.), in addition, patients infused with blood products, with intent to treat iron deficiency anemia (IDA). Patient r...
What is the current status of trial NCT05153278?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2018-10-26. Estimated completion is 2020-08-26.
What interventions are being tested in trial NCT05153278?
The interventions under investigation include: Intravenous drug (DRUG), Packed red blood cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT05153278?
This trial is sponsored by Texas Tech University Health Sciences Center, El Paso, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.